Literature DB >> 15819707

Microdysgenesis in epilepsy.

S H Eriksson1, K Malmgren, C Nordborg.   

Abstract

Microdysgenesis is a microscopic malformation of cortical development characterized by heterotopic neurones and abnormal cortical architecture. It has been described in primary generalized and partial epilepsy. Its significance in epileptogenesis is controversial, partly due to lack of consensus of diagnostic criteria. Different terms have also been used for the malformation. Several quantitative studies have been performed of the histopathological aberrations associated with microdysgenesis. A majority of the studies have revealed an increased number of heterotopic neurones in specimens from epilepsy patients. However, the quantitative values given for abnormal numbers of white matter neurones vary greatly between studies and there is no consensus yet on quantitative criteria for microdysgenesis. There have also been conflicting results from studies correlating microdysgenesis with clinical data. Both favourable and worse outcome after epilepsy surgery have been reported in patients with increased numbers of white matter neurones and microdysgenesis. While some studies have shown earlier seizure onset and increased frequency of mental retardation in patients with microdysgenesis, others have not. Differences in inclusion criteria and definition might contribute to the contradictory results. There is some evidence that microdysgenesis could be important in epileptogenesis, but the mechanisms involved remain unknown and difficult to investigate. A consensus on what histopathological criteria to use for the diagnosis of microdysgenesis is needed to explore this further and enable comparisons between centres. There are advantages and disadvantages both with quantitative stereological and with qualitative assessments. It is necessary to evaluate these in the decision on diagnostic criteria, if possible taking both qualitative and quantitative aspects into account.

Entities:  

Mesh:

Year:  2005        PMID: 15819707     DOI: 10.1111/j.1600-0404.2005.00386.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  7 in total

1.  Evaluation of cortical thickness and brain volume on 3 Tesla magnetic resonance imaging in children with frontal lobe epilepsy.

Authors:  Feride Kural Rahatli; Taner Sezer; Arzu Ceylan Has; Ahmet Muhtesem Agildere
Journal:  Neurol Sci       Date:  2019-12-04       Impact factor: 3.307

2.  Brain tissue compartment density estimated using diffusion-weighted MRI yields tissue parameters consistent with histology.

Authors:  Farshid Sepehrband; Kristi A Clark; Jeremy F P Ullmann; Nyoman D Kurniawan; Gayeshika Leanage; David C Reutens; Zhengyi Yang
Journal:  Hum Brain Mapp       Date:  2015-06-11       Impact factor: 5.038

3.  Grey and white matter abnormalities in temporal lobe epilepsy with and without mesial temporal sclerosis.

Authors:  Cathy Scanlon; Susanne G Mueller; Ian Cheong; Miriam Hartig; Michael W Weiner; Kenneth D Laxer
Journal:  J Neurol       Date:  2013-06-11       Impact factor: 4.849

4.  Focal cortical dysplasias in autism spectrum disorders.

Authors:  Manuel F Casanova; Ayman S El-Baz; Shweta S Kamat; Brynn A Dombroski; Fahmi Khalifa; Ahmed Elnakib; Ahmed Soliman; Anita Allison-McNutt; Andrew E Switala
Journal:  Acta Neuropathol Commun       Date:  2013-10-11       Impact factor: 7.801

5.  Increased prevalence of minor physical anomalies in patients with epilepsy.

Authors:  Dalma Tényi; Tamás Tényi; Györgyi Csábi; Sára Jeges; Beáta Bóné; Katalin Lőrincz; Norbert Kovács; József Janszky
Journal:  Sci Rep       Date:  2022-08-12       Impact factor: 4.996

6.  Neuropathology of temporal lobe epilepsy.

Authors:  Fahd Al Sufiani; Lee Cyn Ang
Journal:  Epilepsy Res Treat       Date:  2012-04-12

7.  Structural changes in the temporal lobe and piriform cortex in frontal lobe epilepsy.

Authors:  M Centeno; C Vollmar; J Stretton; M R Symms; P J Thompson; M P Richardson; J O'Muircheartaigh; J S Duncan; M J Koepp
Journal:  Epilepsy Res       Date:  2014-03-28       Impact factor: 2.991

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.